BEHANDLINGSGRUPP in English translation

• treatment group
• treatment arm

Examples of using Behandlingsgrupp in Swedish and their translations into English

Behandlingsgrupp(trastuzumab emtansin): trastuzumab emtansin 3, 6 mg/kg intravenöst under 30-90 minuter under dag 1 i en 21-dagars behandlingscykel.
Trastuzumab emtansine arm: trastuzumab emtansine 3.6 mg/kg intravenously over 30-90 minutes on Day 1 of a 21-day cycle.

Cirka 98% av patienterna(i varje behandlingsgrupp) fick antitrombotiska läkemedel(heparin,
Approximately 98% of patients(in each of the treatment groups) received antithrombins(heparin,

Ett Kaplan Meier diagram av tid till återfall per behandlingsgrupp redovisas i figur 1.
A Kaplan Meier plot of time to relapse by treatment group is shown in Figure 1.

Tabell 8 visar bestående virologiskt svar per behandlingsgrupp hos patienter som inte hade svarat på tidigare behandling och som var tidiga responders
Table 8 presents sustained virologic response per treatment arm in patients who had failed previous therapy that were early responders

Cirka 40% av patienterna(i varje behandlingsgrupp) fick GPIIb/IIIa hämmare som understödjande behandling för den perkutana koronarinterventionen ingen information finns tillgänglig angående typ av GPIIb/IIIa hämmare som användes.
Approximately 40% of patients(in each of the treatment groups) received GPIIb/IIIa inhibitors in support of PCI no information available regarding the type of GP IIb/IIIa inhibitor used.

25% av patienterna i respektive behandlingsgrupp var 65 år eller äldre;
25% of patients in each treatment arm were 65 years of age

Biverkningar som rapporterades av prövarna som möjligtvis, sannolikt eller definitivt relaterade till den aktiva substansen är förtecknade nedan, om de inträffade hos ≥ 1% av patienterna i en behandlingsgrupp i ettårsstudien eller hos ≥ 1% av patienterna som behandlades med alendronat 10 mg dagligen och med högre incidens än hos patienter som behandlades med placebo i treårsstudier.
Adverse reactions reported by the investigators as possibly, probably or definitely related to the active substance are presented below if they occurred in≥ 1% of any in the treatment groups in the one-year study or in≥ 1% of the patients who were treated with alendronate 10 mg per day and with an incidence higher than in patients who were treated with placebo in three-year studies.

Alla behandlingsgrupper hade en signifikant reduktion av HbA1c jämfört med i början av studien.
All treatment groups had a significant reduction in HbA1c compared to baseline.

Patienterna i båda behandlingsgrupperna kvarstod på sina respektive optimala doser i 6 månader.
Patients in each treatment group were maintained at their optimal dose for 6 months.

Skillnaden mellan behandlingsgrupperna nådde nominell statistisk signifikans p=0, 0136.
The difference between the treatment groups reached nominal statistical significance p=0.0136.

Tabell 5 visar svarsfrekvenserna för behandlingsgruppen med sofosbuvir+ peginterferon alfa+ ribavirin.
Table 5 presents the response rates for the treatment group of sofosbuvir+ peginterferon alfa+ ribavirin.

Patienterna i samtliga behandlingsgrupper fick som regel mellan 2
Patients in all treatment groups typically received between 2

Av patienterna i behandlingsgruppen fick stopp för överdriven hårborttagning.
Of the subjects in the treatment group experienced a halt in excessive hair shedding.

Alla behandlingsgrupper hade en reduktion av HbA1c jämfört med utgångsvärdet.
All treatment groups had a reduction in HbA1c compared to baseline.

Uppskattades till 22 dagar i båda behandlingsgrupperna.
Estimated as 22 days in both treatment groups.

Genomsnittlig T- score i ländryggen var vid baseline cirka- 3, 0 i båda behandlingsgrupperna.
The mean baseline lumbar T score was approximately -3.0 in each treatment group.

Totalt 176 patienter med KLL randomiserades till följande två behandlingsgrupper.
A number of 176 patients with CLL were randomized into the following two treatment groups.

Totalt 43% av patienterna i båda behandlingsgrupperna hade tidigare fått strålbehandling.
A total of 43% of patients in both treatment groups had previously received radiotherapy.

trombocyter mellan de båda behandlingsgrupperna.
neutrophils or platelets between both treatment groups.

Kardiovaskulär död var jämnt fördelad över behandlingsgrupperna.
CV deaths were balanced across the treatment groups.